Skip to main content
User Image

Satish Kumar

Researcher

Researcher

College of Medicine and University Hospitals
Strategic Center for Diabetes Research, College of Medicine

Evaluating the relationship between C-peptide levels and insulin resistance in patients with and without diabetic complications

The precise role of C-peptide remains a subject of ongoing research, particularly in the context of type 2 diabetes mellitus (T2DM), characterized by both insulin resistance (IR) and beta cell dysfunction. This study evaluates the association between C-peptide levels and IR, insulin secretion, and beta cell function independent of other risk factors in T2DM patients with and without complications. This cross-sectional study included 91 T2DM participants with or without diabetic complications. Clinical variables, routine biochemical tests, and serum C-peptide levels were measured after overnight fasting. The levels of biomarkers (fasting insulin, C-peptide, resistin, and tumor necrosis factor alpha [TNFα]) were measured using a Randox Evidence biochip analyzer. Homeostatic model assessment (HOMA) of IR and beta-cell function was calculated using the software HOMA 2 calculator. The C-peptide index was also computed using a widely accepted formula. The mean fasting insulin (P < .001), homeostatic model assessment of IR (P = .001), homeostatic model assessment of beta cell function (P = .002), C-peptide index (P < .001), and TNFα (P = .022) were significantly increased with tertiles of C-peptide. Patients with diabetic retinopathy and nephropathy had significantly higher levels of C-peptide. C-peptide levels significantly increased with the number of complications (P = .010). The C-peptide levels were significantly associated with fasting insulin (P < .000), homeostatic model assessment of beta cell function (P = .011), C-peptide index (P < .000), homeostatic model assessment of IR (P < .000), and resistin (P = .018) after adjustment for confounding factors such as age, gender, diabetes duration, body mass index, systolic blood pressure, low-density lipoprotein cholesterol, HbA1c, TNFα, and antidiabetic drugs (metformin and sulfonylurea) in diabetic patients with complications. This study illustrated the clinical utility of C-peptide in microvascular complications such as diabetic nephropathy and diabetic retinopathy. Moreover, C-peptide can be used as an appropriate index for identifying IR in T2DM patients with complications.

Publisher Name
Medicine
more of publication
publications

Purpose

by Khalid Siddiqui, Shaik Sarfaraz Nawaz, Teena P. George, Satish Kumar David, Assim A Alfadda, Mohamed Rafiullah
2025
Published in:
Journal of Diabetes & Metabolic Disorders
publications

Background:

by Assim A. Alfadda, Satish Kumar David, Mohamed Rafiullah, Adnan Mahmood Usmani, Nourhan Mohamed
2026
Published in:
Journal of Nature and Science of Medicine
publications

The precise role of C-peptide remains a subject of ongoing research, particularly in the context of type 2 diabetes mellitus (T2DM), characterized by both insulin resistance (IR) and beta cell…

by Khalid Siddiqui, Salini S. Joy, Shaik Sarfaraz Nawaz, Teena P. George, Satish Kumar David, Muhammad Mujammami, Assim A. Alfadda, Mohamed Rafiullah
2026
Published in:
Medicine